Cardiff Oncology Cash Conversion Cycle 2011-2025 | CRDF

Annual Cash Conversion Cycle Cardiff Oncology

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
284	396	617	435	-	-	-244	-111	-142	-489	-17.6 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
617	-17.6 K	-1.87 K

Quarterly Cash Conversion Cycle Cardiff Oncology

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
297	351	493	-	296	236	152	-	116	354	795	-	319	224	605	-	373	353	450	-	1.82 K	1.82 K	663	-	346	266	262	-	-2.1 K	126	328	38	182	-154	-59.5	135	-140	-163	-245	114	-390	-1 K	-407	92.4	90.4	93	55.8	153	165	147	94.8	94.3	72.7	370	357	-	164	113	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.82 K	-2.1 K	179

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	31.5	$ 4.68	-	$ 777 M	Canada
Aclaris Therapeutics ACRS	-881	$ 2.9	-	$ 224 M	USA
Catalyst Biosciences CBIO	391	$ 12.12	-2.65 %	$ 798 M	USA
Aptevo Therapeutics APVO	-47.4	$ 1.02	-	$ 282 K	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Celldex Therapeutics CLDX	-6.08 K	$ 26.58	-	$ 1.71 M	USA
Corcept Therapeutics Incorporated CORT	-186	$ 81.99	-	$ 8.46 B	USA
Catalyst Pharmaceuticals CPRX	54.2	$ 24.23	-	$ 2.87 B	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Dynavax Technologies Corporation DVAX	459	$ 11.13	-	$ 1.45 B	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	25	-	-15.15 %	$ 60.3 M	Britain
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	166	$ 26.45	-	$ 1.28 B	USA
Eton Pharmaceuticals ETON	-6.66	$ 16.55	-0.12 %	$ 424 M	USA
Evogene Ltd. EVGN	-32.5	$ 1.05	-	$ 27.9 M	Israel
Exelixis EXEL	5.31	$ 46.61	-	$ 13.5 B	USA
Anika Therapeutics ANIK	270	$ 9.39	-	$ 138 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Axon Enterprise AXON	86.2	$ 591.02	-	$ 44.8 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	174	$ 2.54	-	$ 16 M	USA
AstraZeneca PLC AZN	-58	$ 92.14	-	$ 96.9 B	Britain
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	149	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands